The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Evidence for activation of microglia in patients with psychiatric illnesses
Abstract
Activation of microglia/macrophages is a key event in response to pathological changes in the CNS. HLA-DR is a valuable immunohistochemical marker that specifically reacts with activated microglia cells. In order to elucidate a potential role of microgliosis in severe psychiatric illnesses, post-mortem frontal cortex and hippocampus of patients with schizophrenia (n = 14) and affective disorder (n = 6) and control specimens (n = 13) were studied. Additionally Alzheimer's disease cases (n = 8) were included as a human model system with typical neurodegenerative alterations and microglia activation. All patient groups revealed subjects with abundant microglia immunostaining (schizophrenia, three patients; affective disorder, one patient; Alzheimer's disease, four patients) in both gray and white matter. This finding provides evidence for distinct neuropathological changes in brains of patients with schizophrenia and affective disorder. The activation of microglia cells, which represent a major part of the brain immune response, may help to unravel the pathophysiological processes in severe psychiatric illnesses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this context, the neuropathology of schizophrenia has been reported to be closely associated with cytokines and microglial activation (Bayer et al., 1999; Brown, 2011; Juckel et al., 2011; Meyer et al., 2009; Monji et al., 2009; Najjar et al., 2013; Radewicz et al., 2000; Vuillermot et al., 2010).”
From Perineuronal nets and schizophrenia: The importance of neuronal coatings (2014) · cites this paper as Bayer et al., 1999
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,907
Reactive astrocytes: cellular and molecular cues to biological function
Ridet, J., Privat, A., Malhotra, S. K., & Gage, F. H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01139-9 · Cited by 1,766
Is Schizophrenia a Progressive Neurodevelopmental Disorder? Toward a Unitary Pathogenetic Mechanism
Woods, B. T. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.12.1661 · Cited by 413
Viruses, schizophrenia, and bipolar disorder
Yolken, R. H., & Torrey, Ε. F. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.1.131 · Cited by 360
Recent advances in defining the neuropathology of schizophrenia
Arnold, S. E., & Trojanowski, J. Q. (1996) · Acta Neuropathologica · doi:10.1007/s004010050512 · Cited by 208
Arnold, S. E., Trojanowski, J. Q., Gur, R. E., Blackwell, P., Han, L., & Choi, C. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.3.225 · Cited by 200
Course of Schizophrenia: Neuropsychological Evidence for a Static Encephalopathy
Goldberg, T. E., Hyde, T. M., Kleinman, J. E., & Weinberger, D. R. (1993) · Schizophrenia Bulletin · doi:10.1093/schbul/19.4.797 · Cited by 184
Research works printed but not linked: 1
- American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. In A.P. Association (Eds.), Washington D.C., 1987.
Cited by
Sorted by citations
Items 101–200 of 323
Zhu, F., Zheng, Y., Ding, Y., Liu, Y. H., Zhang, X., Wu, R., Guo, X., & Zhao, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093966 · Cited by 96
Joseph, J., Depp, C. A., Shih, P.-A. B., Cadenhead, K. S., & Schmid‐Schönbein, G. W. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00155 · Cited by 95
Côtel, M.-C., Lenartowicz, E. M., Natesan, S., Modo, M., Cooper, J. D., Williams, S., Kapur, S., & Vernon, A. C. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.08.004 · Cited by 93
Müller, N., Myint, A.-M., & Schwarz, M. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.3/nmueller · Cited by 92
Böttcher, C., Fernández‐Zapata, C., Snijders, G. J. L., Schlickeiser, S., Sneeboer, M. A. M., Kunkel, D., de Witte, L. D., & Priller, J. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00992-2 · Cited by 92
Biase, M. A. D., Zalesky, A., O'Keefe, G. J., Laskaris, L., Baune, B. T., Weickert, C. S., Olver, J. S., McGorry, P. D., Amminger, G. P., Nelson, B., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.193 · Cited by 93
Ohsawa, K., & Kohsaka, S. (2011) · Glia · doi:10.1002/glia.21238 · Cited by 92
Anti-inflammatory treatment in schizophrenia
Müller, N., Myint, A.-M., Krause, D., Weidinger, E., & Schwarz, M. J. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.11.008 · Cited by 89
Gober, R., Ardalan, M., Shiadeh, S. M. J., Duque, L., Garamszegi, S. P., Ascona, M. C., Barreda, A., Sun, X., Mallard, C. E., & Vontell, R. (2021) · Brain Pathology · doi:10.1111/bpa.13003 · Cited by 89
Serum S100B: A Potential Biomarker for Suicidality in Adolescents?
Falcone, T., Fazio, V. J., Lee, C., Simon, B., Franco, K. S. N., Marchi, N., & Janigro, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011089 · Cited by 87
Müller, N., Myint, A.-M., & Schwarz, M. (2012) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-398314-5.00003-9 · Cited by 86
Chen, Z., Revenko, A. S., Singh, P. K., MacLeod, A. R., Norris, E. H., & Strickland, S. (2017) · Blood · doi:10.1182/blood-2016-11-753202 · Cited by 87
Zheng, L. T., Hwang, J., Ock, J., Lee, M., Lee, W., & Suk, K. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05675.x · Cited by 81
Song, X., Fan, X., Song, X., Zhang, J., Zhang, W., Li, X., Gao, J., Harrington, A., Ziedonis, D. M., & Lv, L. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.044 · Cited by 82
Implications of Systemic Inflammation and Periodontitis for Major Depression
Hashioka, S., Inoue, K., Hayashida, M., Wake, R., Oh‐Nishi, A., & Miyaoka, T. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00483 · Cited by 85
In Vivo TSPO Signal and Neuroinflammation in Alzheimer’s Disease
Tournier, B. B., Tsartsalis, S., Ceyzériat, K., Garibotto, V., & Millet, P. (2020) · Cells · doi:10.3390/cells9091941 · Cited by 79
Immune system and glucose metabolism interaction in schizophrenia: A chicken–egg dilemma
Steiner, J. H., Bernstein, H., Schiltz, K., Müller, U., Westphal, S., Drexhage, H. A., & Bogerts, B. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.09.016 · Cited by 81
Stoeber, G., Ben‐Shachar, D., Cardon, M., Falkai, P., Fonteh, A. N., Gawlik, M., Glenthoj, B. Y., Grünblatt, E., Jablensky, A. V., Kim, Y., et al. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970902898980 · Cited by 76
Xu, X., Xiao, X., Yan, Y., & Zhang, T. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.02.026 · Cited by 76
Hou, Y., Wu, C. F., Yang, J., He, X., Bi, X. L., Yu, L., & Guo, T. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.05.006 · Cited by 74
Wegrzyn, D., Juckel, G., & Faissner, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105482 · Cited by 80
Prasad, K. M. R., Upton, C. H., Nimgaonkar, V. L., & Keshavan, M. S. (2014) · Schizophrenia Research · doi:10.1016/j.schres.2014.09.043 · Cited by 75
Kosuge, A., Kunisawa, K., Arai, S., Sugawara, Y., Shinohara, K., Iida, T., Wulaer, B., Kawai, T., Fujigaki, H., Yamamoto, Y., et al. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.05.028 · Cited by 76
Beyond the neuron: Role of non-neuronal cells in stress disorders
Cathomas, F., Holt, L. M., Parise, E. M., Liu, J., Murrough, J. W., Casaccia, P., Nestler, E. J., & Russo, S. J. (2022) · Neuron · doi:10.1016/j.neuron.2022.01.033 · Cited by 72
Anti-inflammatory signaling in schizophrenia
Meyer, U. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.05.014 · Cited by 72
Block, W., Bayer, T. A., Tepest, R., Träber, F., Rietschel, M., Müller, D. J., Schulze, T. G., Honer, W. G., Maier, W., Schild, H. H., et al. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01264-7 · Cited by 71
The role of microglia in neuropsychiatric disorders and suicide
Brisch, R., Wojtylak, S., Saniotis, A., Steiner, J., Gos, T., Kumaratilake, J., Henneberg, M., & Wolf, R. J. (2021) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-021-01334-z · Cited by 74
Mitophagy in depression: Pathophysiology and treatment targets
Tripathi, A., Scaini, G., Barichello, T., Quevedo, J., & Pillai, A. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.08.016 · Cited by 71
Microglial Cells as a Link between Cannabinoids and the Immune Hypothesis of Psychiatric Disorders
Lisboa, S. F. D. S., Gomes, F. V., Guimarães, F. S., & Campos, A. C. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00005 · Cited by 69
Neuroimmune–endocrine crosstalk in schizophrenia and mood disorders
Müller, N., & Schwarz, M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.7.1017 · Cited by 70
Baumann, N., Turpin, J., Lefèvre, M., & Colsch, B. (2002) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(02)00019-0 · Cited by 67
Zuelli, F. M. D. G. C., Brognara, F., Quirino, G. F. S., Hiroki, C. H., Fais, R. S., Del‐Ben, C. M., Ulloa, L., Salgado, H. C., Kanashiro, A., & Loureiro, C. M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00618 · Cited by 73
The Neuroimmunology of Schizophrenia
Annya, M., Smyth, Stephen, M., & Lawrie, S. M. (2013) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2013.11.3.107 · Cited by 68
Snijders, G. J. L., Sneeboer, M. A. M., Fernández-Andreu, A., Udine, E., (NBB-Psy), P. D. P. O. T. N. B. B., Boks, M. P., Ormel, P. R., van Berlekom, A. B., van Mierlo, H. C., Böttcher, C., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00896-z · Cited by 66
Role of P2X7 Receptor in an Animal Model of Mania Induced by D-Amphetamine
Gubert, C., Fries, G. R., Pfaffenseller, B., Ferrari, P., Coutinho‐Silva, R., Morrone, F. B., Kapczinski, F. P., & Battastini, A. M. O. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-9031-z · Cited by 64
Pandey, G. N., Rizavi, H. S., Zhang, H., & Ren, X. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.04.043 · Cited by 67
Clinical Findings Documenting Cellular and Molecular Abnormalities of Glia in Depressive Disorders
Czéh, B., & Nagy, S. A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00056 · Cited by 65
Howes, O. D., Fusar-Poli, P., Bloomfield, M. P., Selvaraj, S., & McGuire, P. (2012) · Current pharmaceutical design · doi:10.2174/138161212799316217 · Cited by 61
Rimmerman, N., Verdiger, H., Goldenberg, H., Naggan, L., Robinson, E., Kozela, E., Gelb, S., Reshef, R., Ryan, K. M., Ayoun, L., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01338-0 · Cited by 62
Foster, F., Kandanearatchi, A., Beasley, C. L., Williams, B. P., Khan, N., Fagerhol, M. K., & Everall, I. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05219.x · Cited by 62
Li, H., Xiao, Y., Han, L., Jia, Y., Luo, S., Zhang, D., Zhang, L., Wu, P., Xiao, C., Kan, W., et al. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.03.002 · Cited by 62
Zhang, L., Zheng, H., Wu, R., Zhu, F., Kosten, T. R., Zhang, X., & Zhao, J. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.004 · Cited by 59
A New Outlook on Mental Illnesses: Glial Involvement Beyond the Glue
Elsayed, M., & Magistretti, P. J. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00468 · Cited by 62
Understanding the role of P2X7 in affective disorders—are glial cells the major players?
Stokes, L., Spencer, S. J., & Jenkins, T. A. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00258 · Cited by 59
Dworsky-Fried, Z., Kerr, B. J., & Taylor, A. M. W. (2020) · Neurobiology of Pain · doi:10.1016/j.ynpai.2020.100045 · Cited by 64
Owen, D. R., Wood, D. M., Archer, J. R. H., & Dargan, P. I. (2015) · Drug and Alcohol Review · doi:10.1111/dar.12356 · Cited by 58
Poletti, S., Vai, B., Smeraldi, E., Cavallaro, R., Colombo, C., & Benedetti, F. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.09.049 · Cited by 58
Uranova, N. A., Vikhreva, O. V., Рахманова, В. И., & Orlovskaya, D. D. (2018) · Schizophrenia · doi:10.1038/s41537-018-0068-2 · Cited by 56
Takahashi, Y., Yu, Z., Sakai, M., & Tomita, H. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00144 · Cited by 58
Prestwood, T. R., Asgariroozbehani, R., Wu, S., Agarwal, S. M., Logan, R. W., Ballon, J. S., Hahn, M., & Freyberg, Z. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113101 · Cited by 67
Selvaraj, S., Bloomfield, P. S., Cao, B., Veronese, M., Turkheimer, F., & Howes, O. D. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.08.063 · Cited by 55
Malavia, T. A., Chaparala, S., Wood, J. A., Chowdari, K. V., Prasad, K. M. R., McClain, L. L., Jegga, A. G., Ganapathiraju, M. K., & Nimgaonkar, V. L. (2017) · Schizophrenia · doi:10.1038/s41537-017-0010-z · Cited by 53
Shao, Y., Peng, H., Huang, Q., Kong, J., & Xu, H. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.046 · Cited by 56
Zhu, F., Zhang, L., Ding, Y., Zhao, J., & Zheng, Y. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.01.017 · Cited by 54
Synaptic elimination by microglia and disturbed higher brain functions
Miyanishi, K., Sato, A., Kihara, N., Utsunomiya, R., & Tanaka, J. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104901 · Cited by 53
Dystrophy of Oligodendrocytes and Adjacent Microglia in Prefrontal Gray Matter in Schizophrenia
Uranova, N. A., Vikhreva, O. V., Рахманова, В. И., & Orlovskaya, D. D. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00204 · Cited by 53
S100B in schizophrenia: an update.
Rothermundt, M., Ahn, J. N., & Jörgens, S. (2009) · PubMed · Cited by 51
Tumour necrosis factor - alpha mediated mechanisms of cognitive dysfunction
Baune, B. T., Camara, M.-L., Eyre, H. A., Jawahar, M. C., Anscomb, H., & Körner, H. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0027-8 · Cited by 50
Kong, X., Zhang, Z., Fu, T., Ji, J., Yang, J., & Gu, Z. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.12.146 · Cited by 55
Chaves-Filho, A. J. M., Macêdo, D. S., de Lucena, D. F., & Maes, M. H. J. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.111975 · Cited by 47
Volk, D. W. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.12.019 · Cited by 47
Ding, S., Hu, Y., Luo, B., Cai, Y., Hao, K., Yang, Y., Zhang, Y., Wang, X., Ding, M., Zhang, H., et al. (2019) · Behavioral and Brain Functions · doi:10.1186/s12993-019-0154-2 · Cited by 48
Petrasch‐Parwez, E., Schöbel, A., Benali, A., Moinfar, Z., Förster, E., Brüne, M., & Juckel, G. (2020) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-020-01107-0 · Cited by 45
Profile of minocycline and its potential in the treatment of schizophrenia
Zhang, L., & Zhao, J. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s64236 · Cited by 45
Marini, S., Berardis, D. D., Vellante, F., Santacroce, R., Orsolini, L., Valchera, A., Girinelli, G., Carano, A., Fornaro, M., Gambi, F., et al. (2016) · Mediators of Inflammation · doi:10.1155/2016/3476240 · Cited by 48
Limoa, E., Hashioka, S., Miyaoka, T., Tsuchie, K., Arauchi, R., Azis, I. A., Wake, R., Hayashida, M., Araki, T., Furuya, M., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0688-2 · Cited by 44
Arauchi, R., Hashioka, S., Tsuchie, K., Miyaoka, T., Tsumori, T., Limoa, E., Azis, I. A., Oh‐Nishi, A., Miura, S., Otsuki, K., et al. (2018) · Brain and Behavior · doi:10.1002/brb3.1028 · Cited by 48
Neuroinflammation in the dorsolateral prefrontal cortex in elderly chronic schizophrenia
López‐González, I., Pinacho, R., Vila, È., Escanilla, A., Ferrer, I., & Ramos, B. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.12.011 · Cited by 43
Altered serine/threonine kinase activity in schizophrenia
McGuire, J. L., Hammond, J. H., Yates, S. D., Chen, D., Haroutunian, V. H., Meador‐Woodruff, J. H., & McCullumsmith, R. E. (2014) · Brain Research · doi:10.1016/j.brainres.2014.04.029 · Cited by 43
Tang, B., Cregger, C., Dean, B., & Thomas, E. A. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2011.09.026 · Cited by 43
Relationship between ST8SIA2, polysialic acid and its binding molecules, and psychiatric disorders
Sato, C., Hane, M., & Kitajima, K. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.04.015 · Cited by 44
Microglial Activation and Psychotic Disorders: Evidence from Pre-clinical and Clinical Studies
Barichello, T., Simões, L. R., Quevedo, J., & Zhang, X. Y. (2019) · Current topics in behavioral neurosciences · doi:10.1007/7854_2018_81 · Cited by 43
Jinno, S., & Kosaka, T. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.04.028 · Cited by 42
Xu, L., Zhang, D., Shoji, H., Duan, C., Zhang, G., Isaji, T., Wang, Y., Fukuda, T., & Gu, J. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.12.008 · Cited by 42
Alzarea, S. I., & Rahman, S. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.05.018 · Cited by 43
Overlapping evidence of innate immune dysfunction in psychotic and affective disorders
Hughes, H. K., & Ashwood, P. (2020) · Brain, Behavior, & Immunity - Health · doi:10.1016/j.bbih.2020.100038 · Cited by 39
Neuropsychiatric Autoimmune Encephalitis without VGKC-Complex, NMDAR, and GAD Autoantibodies
Najjar, S., Pearlman, D. M., Devinsky, O., Najjar, A., Nadkarni, S. S., Butler, T., & Zagzag, D. (2013) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e31828b6531 · Cited by 41
Is there a role for the nuclear receptor PPARγ in neuropsychiatric diseases?
García‐Bueno, B., Perez‐Nievas, B. G., & Leza, J. C. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000970 · Cited by 41
Carter, C. (2011) · Journal of Pathogens · doi:10.4061/2011/128318 · Cited by 42
The role of macrophage polarization on bipolar disorder: Identifying new therapeutic targets
Ascoli, B. M., Géa, L. P., Colombo, R., Barbé‐Tuana, F. M., Kapczinski, F. P., & Rosa, A. R. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416642846 · Cited by 40
Neuroinflammation in Schizophrenia: A Critical Review and The Future
Arıcıoğlu, F., Özkartal, C. Ş., Ünal, G., Dursun, S. M., Çetin, M., & Müller, N. (2016) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20161123044657 · Cited by 40
Perinatal complications and schizophrenia: involvement of the immune system
Jenkins, T. A. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00110 · Cited by 42
Monocyte-Derived Dendritic Cells in Bipolar Disorder
Knijff, E. M., Ruwhof, C., de Wit, H. J., Kupka, R., Vonk, R., Akkerhuis, G. W., Nolen, W. A., & Drexhage, H. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.041 · Cited by 39
Figueiredo, C. P., Fontes-Dantas, F. L., Poian, A. T. D., & Clarke, J. R. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108841 · Cited by 37
Deficient Autophagy in Microglia Aggravates Repeated Social Defeat Stress-Induced Social Avoidance
Sakai, M., Yu, Z., Hirayama, R., Nakasato, M., Kikuchi, Y., Ono, C., Komatsu, H., Nakanishi, M., Yoshii, H., Stellwagen, D., et al. (2022) · Neural Plasticity · doi:10.1155/2022/7503553 · Cited by 37
Varghese, S. M., Patel, S., Nandan, A., Jose, A., Ghosh, S., Sah, R. K., Menon, B., Athira, K. V., & Chakravarty, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04205-5 · Cited by 39
Microglia-derived neuregulin expression in psychiatric disorders
Ikawa, D., Makinodan, M., Iwata, K., Ohgidani, M., Kato, T. A., Yamashita, Y., Yamamuro, K., Kimoto, S., Toritsuka, M., Yamauchi, T., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.01.003 · Cited by 40
Glial mechanisms underlying major depressive disorder: Potential therapeutic opportunities
Rahman, S., & Alzarea, S. I. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.010 · Cited by 36
Zhu, Y., Webster, M. J., Murphy, C. E., Middleton, F. A., Massa, P. T., Liu, C., Dai, R., & Weickert, C. S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.858989 · Cited by 39
Wegrzyn, D., Freund, N., Faissner, A., & Juckel, G. (2021) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2021.637549 · Cited by 37
Role of neuroglia in neuropathic pain and depression
Liu, Q., Li, R., Yang, W., Cui, R., & Li, B. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105957 · Cited by 35
Regulation of the E/I-balance by the neural matrisome
Mueller-Buehl, C., Wegrzyn, D., Bauch, J., & Faissner, A. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1102334 · Cited by 35
Telford, J. E., Bones, J., McManus, C. A., Saldova, R., Manning, G., Doherty, M., Leweke, F. M., Rothermundt, M., Guest, P. C., Rahmoune, H., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr300218h · Cited by 33
T cell responses in depressed mice induced by chronic unpredictable mild stress
Shi, W., Zhang, S., Lu, Y., Wang, Y., Zhao, J., & Li, L. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.064 · Cited by 32
Arif, M., Chikuma, T., Ahmed, M. M., Yoshida, S., & Kato, T. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.10.021 · Cited by 32
Corrêa-Velloso, J. C., Gonçalves, M. C., Naaldijk, Y., Oliveira‐Giacomelli, Á., Pillat, M. M., & Ulrich, H. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.033 · Cited by 31
Proton magnetic resonance spectroscopy and thought disorder in childhood schizophrenia
Seese, R. R., O’Neill, J., Hudkins, M. R., Siddarth, P., Levitt, J. G., Tseng, B., Wu, K. N., & Caplan, R. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.07.011 · Cited by 30
(Micro)Glia as Effectors of Cortical Volume Loss in Schizophrenia
Mallya, A. P., & Deutch, A. Y. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby088 · Cited by 30
Zhu, F., Liu, Y., Zhao, J., & Zheng, Y. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.01.021 · Cited by 29
Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders
Debnath, M., Doyle, K., Langan, C., McDonald, C., Leonard, B., & Cannon, D. (2011) · Translational Neuroscience · doi:10.2478/s13380-011-0019-0 · Cited by 28
Metadata
- Authors
- Bayer, T. A., Buslei, R., Havas, L., & Falkai, P.
- Affiliations
- University of Bonn (DE)
- Corresponding author
- Bayer, Thomas A
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 1999-08
- Volume
- 271
- Issue
- 2
- Pages
- 126-128
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2069782517
- Cited by
- 323
- References
- 19
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 7 · 2022: 11 · 2021: 20 · 2020: 13 · 2019: 13 · 2018: 26 · 2017: 22 · 2016: 18 · 2015: 22 · 2014: 26 · 2013: 27 · 2012: 18
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- microglial activation, HLA-DR, schizophrenia, mood disorders, bipolar disorder, Alzheimer's disease, postmortem brain, frontal cortex, hippocampus, neuroinflammation, brain immune response, neuropathology
- MeSH terms
- Aged, Mental Disorders, Female, HLA-DR Antigens, Humans, Immunohistochemistry, Macrophage Activation, Male, Middle Aged, Schizophrenia, Microglia, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review